Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood–brain barrier: kinetics and metabolism in the rat
- 1 January 2005
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 32 (1), 87-93
- https://doi.org/10.1016/j.nucmedbio.2004.06.007
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluationNuclear Medicine and Biology, 2003
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsNew England Journal of Medicine, 2003
- Fully automated high yield synthesis of (R)‐ and (S)‐[11C]verapamil for measuring P‐glycoprotein function with positron emission tomographyJournal of Labelled Compounds and Radiopharmaceuticals, 2002
- Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humansPharmacogenetics, 2002
- [11]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancyNuclear Medicine and Biology, 2001
- In vivo measurement of [11C]verapamil kinetics in human tissuesEuropean Journal of Clinical Pharmacology, 2001
- Brain kinetics of (R)- and (S)-[N-methyl-11C]ketamine in the rhesus monkey studied by positron emission tomography (PET)Nuclear Medicine and Biology, 1994
- Stereoselective binding of 11C-raclopride in living human brain ? a search for extrastriatal central D2-dopamine receptors by PETPsychopharmacology, 1988
- Clinical Pharmacokinetics of Verapamil, Nifedipine and DiltiazemClinical Pharmacokinetics, 1986
- Pharmacokinetics of (+)‐, (‐)‐ and (+/‐)‐verapamil after intravenous administration.British Journal of Clinical Pharmacology, 1984